Inist Bio Pharmaceutical Co., Ltd.
Inist Bio Co., Ltd. is a South Korean company founded in 2002. It is specialized in developing raw material medicine, as well as its synthesis technology.
Focused on innovation and change, the company is committed to conducting research and creating high-quality generic raw materials and new salt incrementally modified drugs ( known as IMDs). Inist Bio is supplying these products both overseas and domestically.
Based on sophisticated technology, the company has developed a wide variety of first generic raw materials. This resulted in the development of innovative new drugs, including the following products: a contrast medium for heart disease, and a calcium channel blocker anticancer drug.
No products found